Global Memantine Market, By Drug Class (N-Methyl-D-aspartate (NMDA) Receptor Antagonist, Others), Application (Alzheimer's Disease, Others), Demographic (Adult, Pediatric), Dosage Form (Tablets,, Oral Solution, Extended Release Capsule), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Analysis and Insights Global Memantine Market
Memantine market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 7.20% in the above mentioned forecast period.
Memantine is N-Methyl-D-aspartate (NMDA) receptor antagonist. It is a prescription medication used to treat moderate to severe dementia (confusion) caused by Alzheimer's disease. It is not a cure for Alzheimer's disease, although it may help with memory, alertness, and daily functions. This medicine acts by inhibiting the function of a natural molecule in the brain called glutamate, which is connected to Alzheimer's disease symptoms. Namenda XR and Namenda are the different brand names for memantine.
The rise in the prevalence of Alzheimer's disease across the world will act a major driver for the expansion of memantine market. Furthermore, upsurge in the number of pipe line studies, increasing geriatric population and rising healthcare expenditure are the factors that will expand the memantine market. Other factors including changing lifestyle and rising awareness will positively impact the market growth rate. Additionally, advancement in the medical technology, growing government funding and rising level of disposable incomes are the factors that will escalate the growth rate of memantine market.
Moreover, the rise in the research and development activities and emerging new markets will provide beneficial opportunities for the memantine market in the forecast period of 2022-2029.
However, high cost of the drug and side effects associated with memantine such headache, nausea, vomiting, dizziness, nervousness, seizures and others. All these factors hamper the market growth. Lack of awareness and growing number of expired patents of drugs will further challenge the memantine market in the forecast period mentioned above.
This memantine market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the memantine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Memantine Market Scope and Market Size
The memantine market is segmented on the basis of drug class, application, demographic, dosage form, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of drug class, the memantine market is segmented into N-Methyl-D-aspartate (NMDA) receptor antagonist and others.
- On the basis of application, the memantine market is segmented into Alzheimer's disease and others.
- On the basis of demographic, the memantine market is segmented into adult, and pediatric.
- On the basis of dosage form, the memantine market is segmented into tablets, oral solution, and extended release capsule. Tablets are further sub-segmented into 5mg, and 10mg. Extended release capsule are further sub-segmented into 7mg, 14mg, 21mg and 28mg. Oral solution is further sub-segmented into 2mg/ml.
- On the basis of end-users, the memantine market is segmented into clinic, hospital and others.
The memantine market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Memantine Market Country Level Analysis
Memantine market is analyzed and market size information is provided by the country, drug class, application, demographic, dosage form, end-users and distribution channel as referenced above.
The countries covered in the memantine market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the memantine market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing research and development activities and growing government support in this region.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Memantine market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Memantine Market Share Analysis
Memantine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to memantine market research.
Some of the major players operating in the memantine market are DAIICHI SANKYO COMPANY, LIMITED., Novartis AG, Allergan, Sanofi, Lupin, Eisai Co., Ltd., Johnson & Johnson Private Limited, Dr. Reddy’s Laboratories Ltd., H. Lundbeck A/S, ONO PHARMACEUTICAL CO., LTD., Merz Pharma, Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Apotex Inc., and Sun Pharmaceutical Industries Ltd., among others.
SKU-